In a significant development for South Africans managing their weight, Novo Nordisk has cut the price of Wegovy for the second time since the drug launched locally in August 2024. The latest reduction, announced in March 2026, signals growing competition in the GLP-1 weight loss market and brings this life-changing medication a step closer to affordability for more South Africans.
Medical Disclaimer: Wegovy is a prescription medication. It must be prescribed by a registered medical practitioner. This article is for educational purposes only. Always consult your doctor before starting any new medication.
Why Has Novo Nordisk Cut the Price Again?
The weight loss injection market in South Africa has become increasingly competitive. Several factors are driving pricing pressure:
- Mounjaro (tirzepatide) competition: Eli Lilly's dual-action drug has been gaining market share with stronger weight loss outcomes
- Generic semaglutide: Compounding pharmacies and generic versions of semaglutide have been eating into branded Wegovy's patient base
- Access concerns: Novo Nordisk has faced public and media criticism for pricing Wegovy out of reach for most South Africans who need it
- Global strategy: Novo Nordisk has been implementing tiered pricing in developing markets as part of a broader access initiative
The result is that South Africans who were watching the price and waiting for it to come down may now want to revisit their options with their doctor.
Wegovy vs Ozempic: What's the Difference?
Many people are confused about the difference between Wegovy and Ozempic — they both contain semaglutide, the same active ingredient. The key differences are:
| Feature | Wegovy | Ozempic |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| Approved for | Weight management | Type 2 diabetes (often used off-label for weight loss) |
| Maximum dose | 2.4mg weekly | 1mg or 2mg weekly |
| Average weight loss | ~15% body weight | ~10–12% body weight |
| Medical aid coverage (SA) | Rarely covered for obesity alone | More likely covered for T2 diabetes diagnosis |
Wegovy is the purpose-built weight loss version — it reaches a higher dose and is clinically proven to produce around 15% average body weight loss over 68 weeks. For a 100kg person, that's approximately 15kg.
Is Wegovy Now Affordable in South Africa?
Even after the second price reduction, Wegovy remains expensive for most South Africans. While exact current prices may vary between pharmacies (Clicks, Dis-Chem, Medirite), the general cost structure for a monthly supply puts it in the range of R3,000 to R6,000 per month depending on the dose stage — down meaningfully from launch prices that exceeded R8,000–R10,000 per month for the higher doses.
Here's the financial reality:
- Wegovy treatment typically lasts 12–18 months minimum for full effect
- Most South African medical aids do not cover Wegovy for obesity without a diabetes diagnosis
- Stopping the medication often leads to weight regain — ongoing use may be necessary
- For comparison, Mounjaro (tirzepatide) tends to be similarly priced but offers stronger results
Wegovy Dosing Schedule
Wegovy is a once-weekly injection that follows a gradual dose escalation to minimise side effects:
- Weeks 1–4: 0.25mg weekly
- Weeks 5–8: 0.5mg weekly
- Weeks 9–12: 1.0mg weekly
- Weeks 13–16: 1.7mg weekly
- Week 17 onwards: 2.4mg weekly (maintenance dose)
If you cannot tolerate the 2.4mg maintenance dose, your doctor may keep you at 1.7mg.
Side Effects to Know About
The most common side effects of Wegovy are digestive and tend to improve as your body adjusts:
- Nausea (most common, especially early on)
- Diarrhoea or constipation
- Vomiting
- Stomach discomfort or bloating
- Reduced appetite (this is largely the desired effect)
- Fatigue
Rare but serious side effects include pancreatitis, gallstones, and kidney injury (usually from dehydration). Wegovy is not suitable for people with a personal or family history of medullary thyroid cancer or MEN2 syndrome.
Who Qualifies for Wegovy?
Wegovy is indicated for adults who:
- Have a BMI of 30 or higher (clinically obese), or
- Have a BMI of 27 or higher with at least one weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol
Not sure of your BMI? Use our free BMI Calculator to check right now.
Wegovy vs Generic Semaglutide: Is There a Cheaper Option?
With compounding pharmacies in South Africa producing generic semaglutide, some patients opt for significantly cheaper alternatives. However, there are important differences:
- Generic compounded semaglutide is not SAHPRA-approved as a registered medicine
- Quality and dosing accuracy can vary between compounding pharmacies
- Branded Wegovy pens have built-in dose control and are subject to full clinical-grade manufacturing standards
- Your doctor can advise on the risk/benefit tradeoff for your specific situation
Tips for Getting the Most Out of Wegovy
Wegovy works best as part of a comprehensive approach to weight management:
- Eat protein first at every meal — it preserves muscle mass while losing fat
- Stay hydrated — nausea is worse when you're dehydrated; aim for at least 2 litres of water daily
- Keep meals small — your stomach empties more slowly on Wegovy; large meals cause discomfort
- Exercise regularly — even daily walks significantly boost results
- Avoid alcohol — it interacts poorly with reduced-calorie diets and can worsen side effects
- Track your food — using an app or journal helps maximise the medication's appetite-suppressing effect
How to Get a Wegovy Prescription in South Africa
- Visit your GP or a specialist (endocrinologist, bariatric physician, or obesity medicine specialist)
- Discuss your weight history, BMI, and any relevant health conditions
- If eligible, receive a Wegovy prescription (it is a Schedule 4 medication)
- Take the prescription to Clicks, Dis-Chem, Medirite, or an independent pharmacy
- Check with your medical aid whether any benefit applies to your membership plan
The Bottom Line
The second Wegovy price cut is welcome news for South Africans who have been waiting on the sidelines due to cost. While it remains a significant monthly expense for most households, the lower price point makes it increasingly viable for those in higher income brackets or with supportive medical aid cover.
If you have been struggling with your weight and lifestyle changes alone haven't been enough, it's worth having a frank conversation with your doctor about whether Wegovy — or one of the other GLP-1 options — might be appropriate for you.
Remember: Weight loss injections are tools, not magic solutions. They work best when combined with a healthy diet, regular physical activity, and consistent medical supervision.
Related articles: Ozempic for Weight Loss | Mounjaro (Tirzepatide) | Generic Semaglutide SA | Full GLP-1 Guide | Semaglutide Comparison | Check Your BMI